WASHINGTON, DC and CHESTER, NJ--(Marketwire - October 16, 2007) - Molecular Biometrics, a privately held metabolomics company, presented results of a clinical study investigating the use of metabolomic profiling to establish the maturational stage of oocytes. The findings were reported yesterday at the American Society of Reproductive Medicine’s 63rd Annual Meeting (ASRM) in Washington, D.C. The Company had previously reported that metabolomic profiling can accurately identify viable embryos with the highest reproductive potential for transfer during in vitro fertilization (IVF) procedures.
